These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9707336)

  • 21. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Palma L
    Neurosurgery; 2009 Jun; 64(6):E1206; author reply E1206. PubMed ID: 19487876
    [No Abstract]   [Full Text] [Related]  

  • 22. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative evaluation of recurrent meningiomas.
    Scarpelli M; Montironi R; Sisti S; Mariuzzi GM; Brancorsini D; Collan Y; Rychlicki F; Ansuini G
    Pathol Res Pract; 1989 Nov; 185(5):746-51. PubMed ID: 2626384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metastatic meningioma].
    Fischer HP; Schachenmayr W
    Pathologe; 1991 Mar; 12(2):70-6. PubMed ID: 2057462
    [No Abstract]   [Full Text] [Related]  

  • 25. Can recurrence of meningiomas be predicted?
    Kalala JP; Benoit D; De Ridder L
    Anticancer Res; 2004; 24(4):2319-24. PubMed ID: 15330178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic and proliferative potentials in meningiomas.
    Debiec-Rychter M; Biernat W; Limon J; Kordek R; Izycka E; Borowska-Lehman J; Imieliński B; Liberski PP
    Pol J Pathol; 1999; 50(4):243-8. PubMed ID: 10721264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two cases of atypical meningioma with pulmonary metastases: a comparative cytogenetic analysis of chromosomes 1p and 22 and a review of the literature.
    Frydrychowicz C; Holland H; Hantmann H; Gradistanac T; Hoffmann KT; Mueller W; Meixensberger J; Krupp W
    Neuropathology; 2015 Apr; 35(2):175-83. PubMed ID: 25376227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CNS Resident Award. Malignant meningiomas frequently lose multiple chromosomal regions in addition to 22q: putative meningioma progression loci identified by comparative genomic hybridization.
    Metzger AK; Minn YA; Lieberman D; Bollen AW; Wilson CB; Feuerstein BG
    Clin Neurosurg; 1999; 45():6-7. PubMed ID: 10461493
    [No Abstract]   [Full Text] [Related]  

  • 29. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
    Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
    J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of meningiomas to their nearest environment and its significance for recurrence of the tumor.
    Kunicki A
    Neuropatol Pol; 1986; 24(4):511-20. PubMed ID: 3587655
    [No Abstract]   [Full Text] [Related]  

  • 31. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clear cell (glycogen-rich) meningioma with special reference to spherical collagen deposits.
    Kubota T; Sato K; Kabuto M; Hasegawa M; Kitai R; Nakagawa T; Arai Y; Yamashita J
    Noshuyo Byori; 1995 Mar; 12(1):53-60. PubMed ID: 7795730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningioma with rhabdoid transformation.
    Kesavan S
    Singapore Med J; 2000 Sep; 41(9):464-7. PubMed ID: 11193122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive meningioma: a tumour with high proliferating and "recurrence" potential.
    Suwa T; Kawano N; Oka H; Ito H; Kameya T
    Acta Neurochir (Wien); 1995; 136(3-4):127-31. PubMed ID: 8748841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of apoptotic and proliferation markers in meningiomas.
    Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P
    J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of alkaline phosphatase activity predicts meningioma recurrence.
    Bouvier C; Liprandi A; Colin C; Giorgi R; Quilichini B; Metellus P; Figarella-Branger D
    Am J Clin Pathol; 2005 Aug; 124(2):252-8. PubMed ID: 16040297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant meningioma with a new intracytoplasmic inclusion body.
    Utsuki S; Kawano N; Oka H; Suwa T; Fujii K; Iwabuchi K; Yagishita S
    Clin Neuropathol; 1998; 17(4):216-20. PubMed ID: 9707337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare case of recurrent secretory meningioma with malignant transformation.
    Shivane AG; Chakrabarty A; Baborie A; Thiryayi W; Donaldson MH; Ross S
    Br J Neurosurg; 2006 Aug; 20(4):250-3. PubMed ID: 16954080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.